Genetics of epilepsy

Seminars in Neurology

Volumn 31, Issue 5, 2011, Pages 506-518

  Pandolfo, Massimo ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

brain development; brain metabolism; complex genetics; copy number variation; drug response; drug toxicity; Epilepsy; gene mapping; genetic association studies; ion channel; Mendelian genetics; mutation analysis; neurotransmitter; pharmacogenetics; single nucleotide polymorphism

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; PHENYTOIN;

ABSENCE; ARTICLE; ATONIC SEIZURE; BENIGN CHILDHOOD EPILEPSY; BRAIN DISEASE; CHROMOSOME 12Q; CHROMOSOME 18P; CHROMOSOME 18Q; CHROMOSOME 19P; CHROMOSOME 19Q; CHROMOSOME 1Q; CHROMOSOME 22Q; CHROMOSOME 2Q; CHROMOSOME 4Q; CHROMOSOME 5Q; CHROMOSOME 6Q; CHROMOSOME 8Q; COMPLEX PARTIAL SEIZURE; DRUG EFFICACY; EPILEPSY; EPILEPTOGENESIS; FAMILIAL LATERAL TEMPORAL LOBE EPILEPSY; FAMILIAL MESIAL TEMPORAL LOBE EPILEPSY; FEBRILE CONVULSION; FOCAL EPILEPSY; FRONTAL LOBE EPILEPSY; GENE DELETION; GENE MUTATION; GENERALIZED EPILEPSY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENETICS; GRAND MAL SEIZURE; HEREDITY; HUMAN; IDIOPATHIC DISEASE; LENNOX GASTAUT SYNDROME; MYOCLONIC ASTATIC EPILEPSY; MYOCLONUS EPILEPSY; NERVE EXCITABILITY; PHARMACOGENETICS; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; SEVERE MYOCLONIC EPILEPSY IN INFANCY; STEVENS JOHNSON SYNDROME; SYNAPTIC TRANSMISSION; TEMPORAL LOBE EPILEPSY; TONIC CLONIC SEIZURE; TREATMENT RESPONSE; WEST SYNDROME;

ANTICONVULSANTS; EPILEPSY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PHARMACOGENETICS;

EID: 84856197882     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0031-1299789     Document Type: Article

References (139)

1. Banerjee P N., Filippi D, Allen Hauser W. The descriptive epidemiology of epilepsy-a review. Epilepsy Res 2009 85 1 31-45
2. Mullen S A., Scheffer I E. Translational research in epilepsy genetics: sodium channels in man to interneuronopathy in mouse. Arch Neurol 2009 66 1 21-26
3. Berkovic S F., Howell R A., Hay D A., Hopper J L. Epilepsies in twins: genetics of the major epilepsy syndromes. Ann Neurol 1998 43 4 435-445 (Pubitemid 28231717)
4. Poduri A, Lowenstein D. Epilepsy geneticspast, present, and future. Curr Opin Genet Dev 2011 21 3 325-332
5. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989 30 4 389-399
6. Berg A T., Berkovic S F., Brodie M J. et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010 51 4 676-685
7. Nakayama J. Progress in searching for the febrile seizure susceptibility genes. Brain Dev 2009 31 5 359-365
8. Wallace R H., Berkovic S F., Howell R A., Sutherland G R., Mulley J C. Suggestion of a major gene for familial febrile convulsions mapping to 8q13-21. J Med Genet 1996 33 4 308-312
9. Johnson E W., Dubovsky J, Rich S S. et al. Evidence for a novel gene for familial febrile convulsions, FEB2, linked to chromosome 19p in an extended family from the Midwest. Hum Mol Genet 1998 7 1 63-67 (Pubitemid 28040738)
10. Peiffer A, Thompson J, Charlier C et al. A locus for febrile seizures (FEB3) maps to chromosome 2q23-24. Ann Neurol 1999 46 4 671-678 (Pubitemid 29466451)
11. Nakayama J, Hamano K, Iwasaki N et al. Significant evidence for linkage of febrile seizures to chromosome 5q14-q15. Hum Mol Genet 2000 9 1 87-91 (Pubitemid 30145292)
12. Nabbout R, Prud'homme J-F, Herman A et al. A locus for simple pure febrile seizures maps to chromosome 6q22-q24. Brain 2002 125 Pt 12 2668-2680 (Pubitemid 35423516)
13. Nakayama J, Yamamoto N, Hamano K et al. Linkage and association of febrile seizures to the IMPA2 gene on human chromosome 18. Neurology 2004 63 10 1803-1807 (Pubitemid 39532372)
14. Siren A, Nuutila A, Anttonen A et al. Febrile seizures and idiopathic epilepsy: a clinical and genetic study in a Finnish family. Epilepsia 2006 47 12-12
15. Scheffer I E., Berkovic S F. Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. Brain 1997 120 Pt 3 479-490 (Pubitemid 27153640)
16. Bonanni P, Malcarne M, Moro F et al. Generalized epilepsy with febrile seizures plus (GEFS+): clinical spectrum in seven Italian families unrelated to SCN1A, SCN1B, and GABRG2 gene mutations. Epilepsia 2004 45 2 149-158 (Pubitemid 38174121)
17. Ito M, Yamakawa K, Sugawara T, Hirose S, Fukuma G, Kaneko S. Phenotypes and genotypes in epilepsy with febrile seizures plus. Epilepsy Res 2006 70 Suppl 1 S199-S205
18. Scheffer I, Berkovic S. Generalized (genetic) epilepsy with febrile seizures plus. In: Engel J, Pedley T, eds. Epilepsy: A Comprehensive Textbook. Philadelphia Lippincott, Williams & Wilkins 2008 2553-2558
19. Wallace R H., Wang D W., Singh R et al. Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel beta1 subunit gene SCN1B. Nat Genet 1998 19 4 366-370 (Pubitemid 28357909)
20. Gambardella A, Marini C. Clinical spectrum of SCN1A mutations. Epilepsia 2009 50 Suppl 5 20-23
21. Macdonald R L., Kang J Q., Gallagher M J. Mutations in GABAA receptor subunits associated with genetic epilepsies. J Physiol 2010 588 Pt 11 1861-1869
22. Marini C, Mei D, Parmeggiani L et al. Protocadherin 19 mutations in girls with infantile-onset epilepsy. Neurology 2010 75 7 646-653
23. Depienne C, Trouillard O, Bouteiller D et al. Mutations and deletions in PCDH19 account for various familial or isolated epilepsies in females. Hum Mutat 2011 32 1 E1959-E1975
24. Dravet C. Les épilepsies graves de l'enfant. Vie Med 1978 8 543-548
25. Dravet C. The core Dravet syndrome phenotype. Epilepsia 2011 52 Suppl 2 3-9
26. Zupanc M L. Clinical evaluation and diagnosis of severe epilepsy syndromes of early childhood. J Child Neurol 2009 24 8, Suppl 6S-14S
27. Ohtahara S et al. On the specific age dependent epileptic syndrome: the early- infantile epileptic encephalopathy with suppression-burst. [in Japanese with English abstract]. No To Hattatsu 1976 8 270-279
28. Claes L, Del-Favero J, Ceulemans B, Lagae L, Van Broeckhoven C, De Jonghe P. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 2001 68 6 1327-1332 (Pubitemid 32510608)
29. Marini C, Scheffer I E., Nabbout R et al. The genetics of Dravet syndrome. Epilepsia 2011 52 Suppl 2 24-29
30. Scheffer I E., Zhang Y-H, Jansen F E., Dibbens L. Dravet syndrome or genetic (generalized) epilepsy with febrile seizures plus? Brain Dev 2009 31 5 394-400
31. Marini C, Scheffer I E., Nabbout R et al. SCN1A duplications and deletions detected in Dravet syndrome: implications for molecular diagnosis. Epilepsia 2009 50 7 1670-1678
32. Kamiya K, Kaneda M, Sugawara T et al. A nonsense mutation of the sodium channel gene SCN2A in a patient with intractable epilepsy and mental decline. J Neurosci 2004 24 11 2690-2698 (Pubitemid 38380945)
33. Yu F H., Mantegazza M, Westenbroek R E. et al. Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat Neurosci 2006 9 9 1142-1149 (Pubitemid 44306307)
34. Martin M S., Dutt K, Papale L A. et al. Altered function of the SCN1A voltage-gated sodium channel leads to gamma-aminobutyric acid-ergic (GABAergic) interneuron abnormalities. J Biol Chem 2010 285 13 9823-9834
35. Madia F, Gennaro E, Cecconi M et al. No evidence of GABRG2 mutations in severe myoclonic epilepsy of infancy. Epilepsy Res 2003 53 3 196-200 (Pubitemid 36419612)
36. Kelley S A., Kossoff E H. Doose syndrome (myoclonic-astatic epilepsy): 40 years of progress. Dev Med Child Neurol 2010 52 11 988-993
37. Kossoff E H. Infantile spasms. Neurologist 2010 16 2 69-75
38. Shoubridge C, Fullston T, Gécz J. ARX spectrum disorders: making inroads into the molecular pathology. Hum Mutat 2010 31 8 889-900
39. Kato M, Saitoh S, Kamei A et al. A longer polyalanine expansion mutation in the ARX gene causes early infantile epileptic encephalopathy with suppression-burst pattern (Ohtahara syndrome). Am J Hum Genet 2007 81 2 361-366 (Pubitemid 47236082)
40. Castrén M, Gaily E, Tengström C et al. Epilepsy caused by CDKL5 mutations. Eur J Paediatr Neurol 2011 15 1 65-69
41. Saitsu H, Kato M, Mizuguchi T et al. De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy. Nat Genet 2008 40 6 782-788 (Pubitemid 351748868)
42. Mignot C, Moutard M L., Trouillard O et al. STXBP1-related encephalopathy presenting as infantile spasms and generalized tremor in three patients. Epilepsia 2011 52 10 1820-1827
43. Saitsu H, Kato M, Okada I et al. STXBP1 mutations in early infantile epileptic encephalopathy with suppression-burst pattern. Epilepsia 2010 51 12 2397-2405
44. Kurian M A., Meyer E, Vassallo G et al. Phospholipase C beta 1 deficiency is associated with early-onset epileptic encephalopathy. Brain 2010 133 10 2964-2970
45. Kim D, Jun K S., Lee S B. et al. Phospholipase C isozymes selectively couple to specific neurotransmitter receptors. Nature 1997 389 6648 290-293 (Pubitemid 27406643)
46. Hannan A J., Blakemore C, Katsnelson A et al. PLC-beta1, activated via mGluRs, mediates activity-dependent differentiation in cerebral cortex. Nat Neurosci 2001 4 3 282-288 (Pubitemid 32194876)
47. Böhm D, Schwegler H, Kotthaus L et al. Disruption of PLC-beta 1-mediated signal transduction in mutant mice causes age-dependent hippocampal mossy fiber sprouting and neurodegeneration. Mol Cell Neurosci 2002 21 4 584-601 (Pubitemid 36062716)
48. Mulley J C., Heron S E., Dibbens L M. Proposed genetic classification of the benign familial neonatal and infantile epilepsies. Epilepsia 2011 52 3 649-650
49. Yamamoto H, Okumura A, Fukuda M. Epilepsies and epileptic syndromes starting in the neonatal period. Brain Dev 2011 33 3 213-220
50. Singh N A., Westenskow P, Charlier C et al, BFNC Physician Consortium. KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions: expansion of the functional and mutation spectrum. Brain 2003 126 Pt 12 2726-2737 (Pubitemid 37463091)
51. Volkers L, Rook M B., Das JHG et al. Functional analysis of novel KCNQ2 mutations found in patients with benign familial neonatal convulsions. Neurosci Lett 2009 462 1 24-29
52. Soldovieri M V., Cilio M R., Miceli F et al. Atypical gating of M-type potassium channels conferred by mutations in uncharged residues in the S4 region of KCNQ2 causing benign familial neonatal convulsions. J Neurosci 2007 27 18 4919-4928 (Pubitemid 46699067)
53. Tzingounis A V., Nicoll R A. Contribution of KCNQ2 and KCNQ3 to the medium and slow afterhyperpolarization currents. Proc Natl Acad Sci U S A 2008 105 50 19974-19979
54. Kanaumi T, Takashima S, Iwasaki H et al. Developmental changes in KCNQ2 and KCNQ3 expression in human brain: possible contribution to the age-dependent etiology of benign familial neonatal convulsions. Brain Dev 2008 30 5 362-369
55. Heron S E., Crossland K M., Andermann E et al. Sodium-channel defects in benign familial neonatal-infantile seizures. Lancet 2002 360 9336 851-852 (Pubitemid 35257950)
56. Liao Y, Anttonen A-K, Liukkonen E et al. SCN2A mutation associated with neonatal epilepsy, late-onset episodic ataxia, myoclonus, and pain. Neurology 2010 75 16 1454-1458
57. Guipponi M, Rivier F, Vigevano F et al. Linkage mapping of benign familial infantile convulsions (BFIC) to chromosome 19q. Hum Mol Genet 1997 6 3 473-477 (Pubitemid 27116469)
58. Swoboda K J., Soong B, McKenna C et al. Paroxysmal kinesigenic dyskinesia and infantile convulsions: clinical and linkage studies. Neurology 2000 55 2 224-230 (Pubitemid 30604622)
59. Vanmolkot KRJ, Kors E E., Hottenga J-J et al. Novel mutations in the Na+, K+-ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions. Ann Neurol 2003 54 3 360-366 (Pubitemid 37072038)
60. Falace A, Filipello F, La Padula V et al. TBC1D24, an ARF6-interacting protein, is mutated in familial infantile myoclonic epilepsy. Am J Hum Genet 2010 87 3 365-370
61. Pan X, Eathiraj S, Munson M, Lambright D G. TBC-domain GAPs for Rab GTPases accelerate GTP hydrolysis by a dual-finger mechanism. Nature 2006 442 7100 303-306 (Pubitemid 44114905)
62. Frittoli E, Palamidessi A, Pizzigoni A et al. The primate-specific protein TBC1D3 is required for optimal macropinocytosis in a novel ARF6-dependent pathway. Mol Biol Cell 2008 19 4 1304-1316 (Pubitemid 351805086)
63. Jaworski J. ARF6 in the nervous system. Eur J Cell Biol 2007 86 9 513-524 (Pubitemid 47233377)
64. Corbett M A., Bahlo M, Jolly L et al. A focal epilepsy and intellectual disability syndrome is due to a mutation in TBC1D24. Am J Hum Genet 2010 87 3 371-375
65. Suzuki T, Delgado-Escueta A V., Aguan K et al. Mutations in EFHC1 cause juvenile myoclonic epilepsy. Nat Genet 2004 36 8 842-849 (Pubitemid 39014101)
66. Ma S, Blair M A., Abou-Khalil B et al. Mutations in the GABRA1 and EFHC1 genes are rare in familial juvenile myoclonic epilepsy. Epilepsy Res 2006 71 2-3 129-134 (Pubitemid 44416190)
67. Léon C, de Nijs L, Chanas G et al. Distribution of EFHC1 or myoclonin 1 in mouse neural structures. Epilepsy Res 2010 88 2-3 196-207
68. Suzuki T, Inoue I, Yamagata T et al. Sequential expression of Efhc1/myoclonin1 in choroid plexus and ependymal cell cilia. Biochem Biophys Res Commun 2008 367 1 226-233
69. Kamp M A., Krieger A, Henry M et al. Presynaptic Ca2.3-containing E-type Ca channels share dual roles during neurotransmitter release. Eur J Neurosci 2005 21 6 1617-1625 (Pubitemid 40646607)
70. de Nijs L, Léon C, Nguyen L et al. EFHC1 interacts with microtubules to regulate cell division and cortical development. Nat Neurosci 2009 12 10 1266-1274
71. Betting L E., Mory S B., Lopes-Cendes I et al. MRI reveals structural abnormalities in patients with idiopathic generalized epilepsy. Neurology 2006 67 5 848-852 (Pubitemid 44394201)
72. Betting L E., Mory S B., Li L M. et al. Voxel-based morphometry in patients with idiopathic generalized epilepsies. Neuroimage 2006 32 2 498-502 (Pubitemid 44164624)
73. Tae W S., Kim S H., Joo E Y. et al. Cortical thickness abnormality in juvenile myoclonic epilepsy. J Neurol 2008 255 4 561-566
74. Cossette P, Liu L, Brisebois K et al. Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy. Nat Genet 2002 31 2 184-189
75. Escayg A, De Waard M, Lee D D. et al. Coding and noncoding variation of the human calcium-channel beta4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia. Am J Hum Genet 2000 66 5 1531-1539 (Pubitemid 30463072)
76. Haug K, Warnstedt M, Alekov A K. et al. Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies. Nat Genet 2003 33 4 527-532 (Pubitemid 36390018)
77. Kleefuss-Lie A, Friedl W, Cichon S et al. CLCN2 variants in idiopathic generalized epilepsy. Nat Genet 2009 41 9 954-955
78. Niemeyer M I., Cid L P., Seplveda F V., Blanz J, Auberson M, Jentsch T J. No evidence for a role of CLCN2 variants in idiopathic generalized epilepsy. Nat Genet 2010 42 1 3
79. Sander T, Schulz H, Saar K et al. Genome search for susceptibility loci of common idiopathic generalised epilepsies. Hum Mol Genet 2000 9 10 1465-1472 (Pubitemid 30386700)
80. D'Agostino D, Bertelli M, Gallo S et al. Mutations and polymorphisms of the CLCN2 gene in idiopathic epilepsy. Neurology 2004 63 8 1500-1502 (Pubitemid 39426290)
81. Wallace R H., Marini C, Petrou S et al. Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures. Nat Genet 2001 28 1 49-52 (Pubitemid 32405816)
82. Mullen S A., Suls A, De Jonghe P, Berkovic S F., Scheffer I E. Absence epilepsies with widely variable onset are a key feature of familial GLUT1 deficiency. Neurology 2010 75 5 432-440
83. Suls A, Mullen S A., Weber Y G. et al. Early-onset absence epilepsy caused by mutations in the glucose transporter GLUT1. Ann Neurol 2009 66 3 415-419
84. Seidner G, Alvarez M G., Yeh J I. et al. GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier. Nat Genet 1998 18 2 188-191 (Pubitemid 28082472)
85. Suls A, Dedeken P, Goffin K et al. Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Brain 2008 131 Pt 7 1831-1844 (Pubitemid 351957463)
86. Brockmann K. The expanding phenotype of GLUT1-deficiency syndrome. Brain Dev 2009 31 7 545-552
87. Steinlein O K., Mulley J C., Propping P et al. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 1995 11 2 201-203
88. Aridon P, Marini C, Di Resta C et al. Increased sensitivity of the neuronal nicotinic receptor alpha 2 subunit causes familial epilepsy with nocturnal wandering and ictal fear. Am J Hum Genet 2006 79 2 342-350 (Pubitemid 44141832)
89. De Fusco M, Becchetti A, Patrignani A et al. The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy. Nat Genet 2000 26 3 275-276
90. Combi R, Dalpr L, Malcovati M et al. Evidence for a fourth locus for autosomal dominant nocturnal frontal lobe epilepsy. Brain Res Bull 2004 63 5 353-359 (Pubitemid 38887553)
91. Klaassen A, Glykys J, Maguire J et al. Seizures and enhanced cortical GABAergic inhibition in two mouse models of human autosomal dominant nocturnal frontal lobe epilepsy. Proc Natl Acad Sci U S A 2006 103 50 19152-19157 (Pubitemid 350002842)
92. Crompton D E., Scheffer I E., Taylor I et al. Familial mesial temporal lobe epilepsy: a benign epilepsy syndrome showing complex inheritance. Brain 2010 133 11 3221-3231
93. Kalachikov S, Evgrafov O, Ross B et al. Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat Genet 2002 30 3 335-341
94. Scheel H, Tomiuk S, Hofmann K. A common protein interaction domain links two recently identified epilepsy genes. Hum Mol Genet 2002 11 15 1757-1762 (Pubitemid 34812096)
95. Sirerol-Piquer M S., Ayerdi-Izquierdo A, Morante-Redolat J M. et al. The epilepsy gene LGI1 encodes a secreted glycoprotein that binds to the cell surface. Hum Mol Genet 2006 15 23 3436-3445 (Pubitemid 44811596)
96. Ribeiro PAO, Sbragia L, Gilioli R et al. Expression profile of Lgi1 gene in mouse brain during development. J Mol Neurosci 2008 35 3 323-329
97. Owuor K, Harel N Y., Englot D J. et al. LGI1-associated epilepsy through altered ADAM23-dependent neuronal morphology. Mol Cell Neurosci 2009 42 4 448-457
98. Fukata Y, Lovero K L., Iwanaga T et al. Disruption of LGI1-linked synaptic complex causes abnormal synaptic transmission and epilepsy. Proc Natl Acad Sci U S A 2010 107 8 3799-3804
99. Yu Y E., Wen L, Silva J et al. Lgi1 null mutant mice exhibit myoclonic seizures and CA1 neuronal hyperexcitability. Hum Mol Genet 2010 19 9 1702-1711
100. Lai M, Huijbers MGM, Lancaster E et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 2010 9 8 776-785
101. Irani S R., Alexander S, Waters P et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 2010 133 9 2734-2748
102. Berkovic S F., McIntosh A, Howell R A. et al. Familial temporal lobe epilepsy: a common disorder identified in twins. Ann Neurol 1996 40 2 227-235 (Pubitemid 26274558)
103. Hedera P, Blair M A., Andermann E et al. Familial mesial temporal lobe epilepsy maps to chromosome 4q13.2-q21.3. Neurology 2007 68 24 2107-2112 (Pubitemid 46912128)
104. Baulac S, Picard F, Herman A et al. Evidence for digenic inheritance in a family with both febrile convulsions and temporal lobe epilepsy implicating chromosomes 18qter and 1q25-q31. Ann Neurol 2001 49 6 786-792 (Pubitemid 32530246)
105. Claes L, Audenaert D, Deprez L et al. Novel locus on chromosome 12q22-q23.3 responsible for familial temporal lobe epilepsy associated with febrile seizures. J Med Genet 2004 41 9 710-714 (Pubitemid 39208613)
106. Xiong L, Labuda M, Li D S. et al. Mapping of a gene determining familial partial epilepsy with variable foci to chromosome 22q11-q12. Am J Hum Genet 1999 65 6 1698-1710 (Pubitemid 30468683)
107. Berkovic S F., Serratosa J M., Phillips H A. et al. Familial partial epilepsy with variable foci: clinical features and linkage to chromosome 22q12. Epilepsia 2004 45 9 1054-1060 (Pubitemid 39238115)
108. Manzini M C., Walsh C. What disorders of cortical development tell us about the cortex: one plus one does not always make two. Curr Opin Genet Dev 2011 21 3 333-339
109. Pal D K., Pong A W., Chung W K. Genetic evaluation and counseling for epilepsy. Nat Rev Neurol 2010 16 8 445-453
110. Altshuler D, Daly M J., Lander E S. Genetic mapping in human disease. Science 2008 322 5903 881-888
111. Shields R. Common disease: are causative alleles common or rare? PLoS Biol 2011 9 1 e1001009
112. Chen Y, Lu J, Pan H et al. Association between genetic variation of CACNA1H and childhood absence epilepsy. Ann Neurol 2003 54 2 239-243 (Pubitemid 36909623)
113. Chioza B, Everett K, Aschauer H et al. Evaluation of CACNA1H in European patients with childhood absence epilepsy. Epilepsy Res 2006 69 2 177-181 (Pubitemid 44304391)
114. Liang J, Zhang Y, Chen Y et al. Common polymorphisms in the CACNA1H gene associated with childhood absence epilepsy in Chinese Han population. Ann Hum Genet 2007 71 Pt 3 325-335 (Pubitemid 46585675)
115. Pal D K., Evgrafov O V., Tabares P et al. BRD2 (RING3) is a probable major susceptibility gene for common juvenile myoclonic epilepsy. Am J Hum Genet 2003 73 2 261-270 (Pubitemid 36920990)
116. Greenberg D A., Cayanis E, Strug L et al. Malic enzyme 2 may underlie susceptibility to adolescent-onset idiopathic generalized epilepsy. Am J Hum Genet 2005 76 1 139-146 (Pubitemid 40023772)
117. Cavalleri G L., Weale M E., Shianna K V. et al. Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: A case-control study. Lancet Neurol 2007 6 11 970-980 (Pubitemid 47570022)
118. Lenzen K P., Heils A, Lorenz S, Hempelmann A, Sander T. Association analysis of malic enzyme 2 gene polymorphisms with idiopathic generalized epilepsy. Epilepsia 2005 46 10 1637-1641 (Pubitemid 44921939)
119. Cavalleri G L., Weale M E., Shianna K V. et al. Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: a case-control study. Lancet Neurol 2007 6 11 970-980 (Pubitemid 47570022)
120. Mulley J C., Mefford H C. Epilepsy and the new cytogenetics. Epilepsia 2011 52 3 423-432
121. Helbig I, Mefford H C., Sharp A J. et al. 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet 2009 41 2 160-162
122. Mefford H C., Muhle H, Ostertag P et al. Genome-wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies. PLoS Genet 2010 6 5 e1000962
123. Heinzen E L., Radtke R A., Urban T J. et al. Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes. Am J Hum Genet 2010 86 5 707-718
124. Kasperavicite D, Catarino C B., Heinzen E L. et al. Common genetic variation and susceptibility to partial epilepsies: a genome-wide association study. Brain 2010 133 Pt 7 2136-2147
125. Depondt C. Pharmacogenetics in neuropsychiatric diseases: epilepsy as a model. Acta Neurol Belg 2006 106 4 157-167 (Pubitemid 46243053)
126. Löscher W, Klotz U, Zimprich F, Schmidt D. The clinical impact of pharmacogenetics on the treatment of epilepsy. Epilepsia 2009 50 1 1-23
127. Siddiqui A, Kerb R, Weale M E. et al. Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N Engl J Med 2003 348 15 1442-1448 (Pubitemid 36407173)
128. Löscher W, Delanty N. MDR1/ABCB1 polymorphisms and multidrug resistance in epilepsy: in and out of fashion. Pharmacogenomics 2009 10 5 711-713
129. Anderson G D. Pharmacokinetic, pharmacodynamic, and pharmacogenetic targeted therapy of antiepileptic drugs. Ther Drug Monit 2008 30 2 173-180 (Pubitemid 351521644)
130. Depondt C, Godard P, Espel R S., Da Cruz A L., Lienard P, Pandolfo M. A candidate gene study of antiepileptic drug tolerability and efficacy identifies an association of CYP2C9 variants with phenytoin toxicity. Eur J Neurol 2011 18 9 1159-1164
131. Tate S K., Singh R, Hung C-C et al. A common polymorphism in the SCN1A gene associates with phenytoin serum levels at maintenance dose. Pharmacogenet Genomics 2006 16 10 721-726 (Pubitemid 44454866)
132. Abe T, Seo T, Ishitsu T, Nakagawa T, Hori M, Nakagawa K. Association between SCN1A polymorphism and carbamazepine-resistant epilepsy. Br J Clin Pharmacol 2008 66 2 304-307
133. Manna I, Gambardella A, Bianchi A et al. A functional polymorphism in the SCN1A gene does not influence antiepileptic drug responsiveness in Italian patients with focal epilepsy. Epilepsia 2011 52 5 e40-e44
134. Pirmohamed M, Lin K, Chadwick D, Park B K. TNFalpha promoter region gene polymorphisms in carbamazepine-hypersensitive patients. Neurology 2001 56 7 890-896 (Pubitemid 32290806)
135. Chung W-H, Hung S-I, Hong H-S et al. Medical genetics: a marker for Stevens-Johnson syndrome. Nature 2004 428 6982 486 (Pubitemid 38480527)
136. Chen P, Lin J-J, Lu C-S et al, Taiwan SJS Consortium. Carbamazepine-induced toxic effects and HLA-B1502 screening in Taiwan. N Engl J Med 2011 364 12 1126-1133
137. Ozeki T, Mushiroda T, Yowang A et al. Genome-wide association study identifies HLA-A3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population. Hum Mol Genet 2011 20 5 1034-1041
138. McCormack M, Alfirevic A, Bourgeois S et al. HLA-A3101 and carbamazepine-induced hypersensitivity reactions in Europeans. N Engl J Med 2011 364 12 1134-1143
139. Lee H Y., Huang Y, Bruneau N et al. Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Reports 2012 1 1-11